Sonic Healthcare Limited

Headquarters: Sydney, NSW, Australia

Founded: 1987. Parts of the company have operated for many decades

Employees: 38,000

CEO: Dr. Colin Stephen Goldschmidt

show_chart ASX: SHL +2.64%

Market Cap

A$14.47 Billion

AUD as of Jan. 1, 2023

US$9.86 Billion

history Market Cap History

Company Description

Sonic Healthcare Limited is a medical company specializing in diagnostics services. It provides services in pathology/laboratory medicine and imaging/radiology. Having grown through international acquisitions, Sonic Healthcare now operates in Australia, New Zealand, United States, United Kingdom, Germany, Switzerland, Belgium, and Ireland

Sonic Healthcare Limited market capitalization over time

Evolution of Sonic Healthcare Limited market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Sonic Healthcare Limited

Detailed Description

Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Stocks & Indices

Sonic Healthcare Limited has the following listings and related stock indices.

Stock: ASX: SHL

Product & Services

Pathology/laboratory medicine and Imaging/radiology

Key People

Dr Colin Goldschmidt (CEO, Managing Director)


Revenue: A$6.2 billion (2019)



Grosvenor Place

Level 22 225 George Street

Sydney, NSW 2000


Phone: 61 2 9855 5444

Fax: 61 2 9878 5066